Melatonin and the Human Hair Follicle

March 2023 | Volume 22 | Issue 3 | 260 | Copyright © March 2023


Published online February 17, 2023

Arash Babadjouni MSa,b*, Minal Reddy BSc*, Rebecca Zhang BSd, Jodie Raffi MDa, Celine H. Phong BSa, Natasha Atanaskova Mesinkovska MD PhDa

aUniversity of California Irvine, Department of Dermatology, Irvine, CA
bMidwestern University - Arizona College of Osteopathic Medicine, Glendale, AZ
cUniversity of California Irvine, School of Medicine, Irvine, CA
dCharles E. Schmidt College of Medicine, Boca Raton, FL

*These authors contributed equally to this work.

Abstract
Background: Melatonin, a pleiotropic hormone, affects the physiological processes including that of the hair follicle. We seek to identify the scientific evidence to support the potential benefits of melatonin in human hair growth.
Objective: To summarize the evidence on the association between melatonin and hair health, denoted by hair growth.
Methods: A literature review using 3 databases (PubMed, Google Scholar, and Cochrane) identified studies investigating the relationship between melatonin and hair loss (2022). The following search terms were used: (hair OR hair loss OR alopecia OR hair growth OR effluvium OR scalp) and (melatonin). Two independent reviewers screened studies for inclusion criteria, and data collection included demographics, melatonin intervention, study type, and effects on hair.
Results: A total of 11 human studies were identified with evidence of melatonin use in subjects with diagnosed alopecia (2,267 patients; 1,140M). Eight of the studies reviewed observed positive outcomes after topical melatonin use in subjects with androgenetic alopecia (AGA). Most studies report improved scalp hair growth (n=8), density (n=4), and hair shaft thickness (n=2) among melatonin users compared with controls. Effective topical melatonin dosage appears to be 0.0033% or 0.1% solution applied once-daily for 90 to 180 days vs 1.5 mg twice-daily oral melatonin supplementation for 180 days.
Conclusion: There is evidence to support melatonin use to facilitate scalp hair growth, particularly in men with AGA. Further studies should include more patients and investigate the mechanism of action.

J Drugs Dermatol. 2023;22(3): doi:10.36849/JDD.6921

Citation: Babadjouni A, Reddy M, Zhang R, et al. Melatonin and the human hair follicle. J Drugs Dermatol. 2023;22(3):260-264. doi:10.36849/JDD.6921

INTRODUCTION

Melatonin is synthesized primarily in the pineal gland, and in several extra-pineal sites including the retina, skin, bone marrow, cerebellum, and gastrointestinal tract.1 Melatonin acts primarily via G-protein coupled membrane receptors, MT1 and MT2, at target sites in the central nervous system. MT1 membrane receptors are also present in the outer and inner root sheaths of cutaneous keratinocytes and fibroblasts.2

Melatonin is known as the main regulator of circadian rhythm but has also been implicated in the modulation of hair growth, cycle regulation, and pigmentation in both animal and human studies. In vitro studies and use of long-term subcutaneous melatonin implants in large animals, such as goats and dogs, support the ability of melatonin to stimulate hair growth and density.3-6 However, even among the same animal species, such as minks, conflicting studies describe decrease or increase in hair growth following melatonin treatment.7

Melatonin supplements are popular over the counter option touted as a panacea for hair growth not only on social media but also on physician meeting platforms without much convincing evidence. In this systematic review, we identify and analyze evidence on the qualitative and quantitative effects of melatonin on hair growth in human clinical studies in an attempt to determine its use as a supplement that improves hair growth.

MATERIALS AND METHODS

A primary literature search was conducted using the PubMed, Google Scholar, and Cochrane databases in March 2022 using search criteria (hair OR hair loss OR alopecia OR effluvium OR scalp) AND (melatonin). Initially, 234 articles from the years 1966 to 2021 were identified. Inclusion criteria were as follows: studies investigating melatonin supplementation in hair growth/loss cycles in human subjects, clinically relevant randomized controlled trials (RCT), cohort studies, cross-sectional studies, case reports, observational studies, case series, retrospective studies, and clinical trials. Exclusion criteria included studies not written in English and studies not conducted on human subjects. Following title/abstract screening and duplicate removal, 59 articles met the criteria for inclusion. These articles underwent full article evaluation, as shown in the PRISMA flow diagram.